| Net Cash Provided by (Used in) Operating Activities |
$2,720,000,000 |
USD |
-5.5% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$1,085,000,000 |
USD |
79% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$43,000,000 |
USD |
-102% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
12,000,000,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Common Stock, Shares, Issued |
2,805,961,317 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.33 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,592,000,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$3,496,000,000 |
USD |
81% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$740,000,000 |
USD |
-66% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Gross |
$1,802,000,000 |
USD |
-59% |
Q4 2024 |
FY 2024 |
| Depreciation |
$136,000,000 |
USD |
-11% |
Q3 2025 |
Q3 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$38,000,000 |
USD |
8.6% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$8,777,000,000 |
USD |
-13% |
Q3 2025 |
Q3 2025 |
| Property, Plant and Equipment, Gross |
$4,547,000,000 |
USD |
0.64% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$26,000,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Unrecognized Tax Benefits |
$573,000,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Amortization of Intangible Assets |
$149,000,000 |
USD |
4.2% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$71,000,000 |
USD |
9.2% |
Q1 2025 |
Q1 2025 |